Search Results for "Valcyte"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Valcyte. Results 1 to 3 of 3 total matches.
See also: valganciclovir

Letermovir (Prevymis) for CMV Prophylaxis

   
The Medical Letter on Drugs and Therapeutics • Dec 16, 2019  (Issue 1587)
valganciclovir (Valcyte, and generics) has been preferred over prophylaxis because of the risk of hematologic ...
The FDA has approved letermovir (Prevymis – Merck), a cytomegalovirus (CMV) DNA terminase complex inhibitor, for prophylaxis of CMV infection and disease in CMV-seropositive adult recipients of an allogeneic hematopoietic cell transplant (HCT). Letermovir is the first CMV DNA terminase complex inhibitor to be approved in the US and the only drug specifically indicated for CMV prophylaxis in HCT patients. It is not approved for treatment of CMV infection.
Med Lett Drugs Ther. 2019 Dec 16;61(1587):199-201 |  Show IntroductionHide Introduction

Drugs That May Cause Psychiatric Symptoms

   
The Medical Letter on Drugs and Therapeutics • Dec 15, 2008  (Issue 1301)
reports (Bactrim*) Valganciclovir (Valcyte) Depression, psychosis, hallucinations, confusion ...
Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment could also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression.

Click here to view the free full article.
Med Lett Drugs Ther. 2008 Dec 15;50(1301):100-3 |  Show IntroductionHide Introduction

Antiviral Drugs

   
Treatment Guidelines from The Medical Letter • Mar 01, 2013  (Issue 127)
Valganciclovir – 900 mg PO bid x 21d, 3408.60 Valcyte then 900 mg once daily Foscarnet – generic 60 mg/kg IV ...
The drugs of choice for treatment of viral infections (other than HIV) and their dosages are listed in Tables 1-6 on the pages that follow. Some of the indications and dosages recommended here have not been approved by the FDA. Vaccines used for the prevention of viral infections are discussed elsewhere.
Treat Guidel Med Lett. 2013 Mar;11(127):19-30 |  Show IntroductionHide Introduction